Colorectal Carcinoma Antibodies

Santa Cruz Biotechnology features a diverse variety of Colorectal Carcinoma monoclonal antibodies for advanced research in cancer biology. Colorectal Carcinoma Antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Colorectal carcinoma is a significant health concern, characterized by the uncontrolled growth of cells in the colon or rectum. Understanding the molecular mechanisms underlying this disease is crucial for developing targeted therapies and improving patient outcomes. Molecular markers associated with colorectal carcinoma play vital roles in cell signaling, proliferation, and apoptosis, making them essential targets for research. Investigating specific protein interactions and expression patterns helps reveal new insights into cancer development and progression. Advanced research techniques using monoclonal antibodies enable scientists to explore cellular pathways and potential therapeutic targets. Multiple detection methods allow for comprehensive analysis of protein expression and localization in various experimental settings. Santa Cruz Biotechnology monoclonal antibodies for colorectal carcinoma research support scientists worldwide in their mission to advance cancer research and develop more effective treatments.